Jean–Frédéric Colombel

25.1k total citations · 5 hit papers
209 papers, 14.1k citations indexed

About

Jean–Frédéric Colombel is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Jean–Frédéric Colombel has authored 209 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Genetics, 133 papers in Epidemiology and 76 papers in Surgery. Recurrent topics in Jean–Frédéric Colombel's work include Inflammatory Bowel Disease (169 papers), Microscopic Colitis (120 papers) and Eosinophilic Esophagitis (33 papers). Jean–Frédéric Colombel is often cited by papers focused on Inflammatory Bowel Disease (169 papers), Microscopic Colitis (120 papers) and Eosinophilic Esophagitis (33 papers). Jean–Frédéric Colombel collaborates with scholars based in France, United States and Belgium. Jean–Frédéric Colombel's co-authors include William J. Sandborn, Antoine Cortot, Pierre Desreumaux, Laurent Peyrin‐Biroulet, Corinne Gower‐Rousseau, Jacques Bélaïche, Mathias Chamaillard, Habib Zouali, Gilles Thomas and Jean‐Pierre Hugot and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jean–Frédéric Colombel

196 papers receiving 13.8k citations

Hit Papers

Association of NOD2 leuci... 2001 2026 2009 2017 2001 2008 2012 2013 2021 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
    2001 4.1k citations Mathias Chamaillard, Jacques Bélaïche et al. profile →
  2. Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
    2008 770 citations Edward V. Loftus, William J. Sandborn et al. Gastroenterology profile →
  3. Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
    2012 460 citations Paul Rutgeerts, William J. Sandborn et al. Gastroenterology profile →
  4. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
    2013 363 citations Laurent Peyrin‐Biroulet, Walter Reinisch et al. Gut profile →
  5. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
    2021 335 citations William J. Sandborn, Subrata Ghosh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean–Frédéric Colombel France 49 8.9k 6.6k 4.2k 3.7k 2.6k 209 14.1k
Jack Satsangi United Kingdom 58 9.4k 1.1× 6.3k 1.0× 3.1k 0.7× 4.0k 1.1× 2.1k 0.8× 222 13.2k
Corinne Gower‐Rousseau France 43 8.8k 1.0× 5.7k 0.9× 3.6k 0.9× 3.9k 1.1× 2.5k 0.9× 163 13.2k
Lloyd Mayer United States 64 9.4k 1.1× 6.8k 1.0× 7.7k 1.9× 4.0k 1.1× 2.3k 0.9× 184 19.1k
Curt Tysk Sweden 51 8.4k 0.9× 6.3k 1.0× 3.3k 0.8× 3.7k 1.0× 4.6k 1.7× 137 15.0k
Hans Herfarth United States 55 4.7k 0.5× 4.2k 0.6× 3.0k 0.7× 3.0k 0.8× 3.1k 1.2× 264 12.1k
Antoine Cortot France 62 11.7k 1.3× 8.3k 1.3× 4.7k 1.1× 6.0k 1.6× 3.2k 1.2× 275 19.3k
P. Rutgeerts Belgium 51 7.5k 0.8× 5.7k 0.9× 2.1k 0.5× 3.4k 0.9× 1.3k 0.5× 189 11.0k
Jacques Bélaïche Belgium 44 6.0k 0.7× 4.0k 0.6× 3.5k 0.8× 2.7k 0.7× 1.8k 0.7× 166 10.4k
Francesco Pallone Italy 69 5.6k 0.6× 3.8k 0.6× 7.2k 1.7× 3.8k 1.0× 3.2k 1.2× 345 16.1k
Daniël W. Hommes Netherlands 58 5.5k 0.6× 3.7k 0.6× 2.9k 0.7× 2.9k 0.8× 2.8k 1.1× 217 12.6k

Countries citing papers authored by Jean–Frédéric Colombel

Since Specialization
Citations

This map shows the geographic impact of Jean–Frédéric Colombel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean–Frédéric Colombel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean–Frédéric Colombel more than expected).

Fields of papers citing papers by Jean–Frédéric Colombel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean–Frédéric Colombel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean–Frédéric Colombel. The network helps show where Jean–Frédéric Colombel may publish in the future.

Co-authorship network of co-authors of Jean–Frédéric Colombel

This figure shows the co-authorship network connecting the top 25 collaborators of Jean–Frédéric Colombel. A scholar is included among the top collaborators of Jean–Frédéric Colombel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean–Frédéric Colombel. Jean–Frédéric Colombel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yarur, Andrés, et al.. (2025). P0982 Efficacy of upadacitinib in patients with Crohn’s disease and an ostomy: A matched retrospective real-world cohort analysis. Journal of Crohn s and Colitis. 19(Supplement_1). i1824–i1826.
2.
Ardabili, Ashkan Rezazadeh, Alexandros D. Polydorides, & Jean–Frédéric Colombel. (2025). Scrotal Swelling in a Patient With Crohn’s Disease: More Than Meets the Eye. Gastroenterology. 170(1). e5–e8.
3.
Feagan, Brian G., Jean–Frédéric Colombel, Remo Panaccione, et al.. (2024). Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease. SHILAP Revista de lepidopterología. 4(1). 100544–100544. 1 indexed citations
4.
Xu, Zhilu, Keli Yang, Caroline Chevarin, et al.. (2021). Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn’s disease. Gut Microbes. 13(1). 1994833–1994833. 13 indexed citations
5.
Sandborn, William J., Paul Rutgeerts, Jean–Frédéric Colombel, et al.. (2017). Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn’s Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study. Journal of Crohn s and Colitis. 11(7). 811–819. 27 indexed citations
6.
Shmidt, Eugenia, Adam C. Winters, Khadija Chaudrey, et al.. (2017). P-040 Assessing Risk Factors Predicting Loss of Response to Vedolizumab in Ulcerative Colitis and Crohn's Disease: Outcomes from the VICTORY Consortium. Inflammatory Bowel Diseases. 23. 2 indexed citations
7.
Fumery, Mathurin, Anne Jacob, Hélène Sarter, et al.. (2015). Efficacy and Safety of Adalimumab After Infliximab Failure in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 60(6). 744–748. 13 indexed citations
8.
Chambrun, Guillaume Pineton de, Luc Dauchet, Corinne Gower‐Rousseau, et al.. (2015). Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case–Control and Cohort Studies. Clinical Gastroenterology and Hepatology. 13(8). 1405–1415.e1. 20 indexed citations
9.
Peyrin‐Biroulet, Laurent, Walter Reinisch, Jean–Frédéric Colombel, et al.. (2013). Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 63(1). 88–95. 363 indexed citations breakdown →
10.
Colombel, Jean–Frédéric. (2012). When should combination therapy for patients with Crohn's disease be discontinued?. PubMed Central. 3 indexed citations
11.
Salleron, Julia, Guillaume Savoye, Jean‐Louis Dupas, et al.. (2011). Long-term outcome of treatment with infliximab in pediatric-onset Crohnʼs disease: A population-based study. Inflammatory Bowel Diseases. 17(10). 2144–2152. 77 indexed citations
12.
Peyrin‐Biroulet, Laurent, Alarcos Cieza, William J. Sandborn, et al.. (2011). Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 61(2). 241–247. 259 indexed citations
13.
Coenen, Michaela, et al.. (2011). Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures. Journal of Crohn s and Colitis. 6(5). 507–517. 25 indexed citations
14.
Rahier, Jean‐François, S. Buche, Laurent Peyrin‐Biroulet, et al.. (2010). Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy. Clinical Gastroenterology and Hepatology. 8(12). 1048–1055. 130 indexed citations
15.
Peyrin‐Biroulet, Laurent, Julia Beisner, Guoxing Wang, et al.. (2010). Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proceedings of the National Academy of Sciences. 107(19). 8772–8777. 161 indexed citations
16.
Hervé, S., Laurent Beaugerie, Yoram Bouhnik, et al.. (2009). Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case–control study. Neurogastroenterology & Motility. 21(11). 1170–1170. 12 indexed citations
17.
Peyrin‐Biroulet, Laurent, Alarcos Cieza, William J. Sandborn, et al.. (2009). Disability in inflammatory bowel diseases: Developing ICF core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health. Inflammatory Bowel Diseases. 16(1). 15–22. 69 indexed citations
18.
Standaert‐Vitse, Annie, Mathias Chamaillard, Marie Joossens, et al.. (2007). Candida albicans carriage and ASCA in familial Crohn's disease. Gastroenterology. 132(4). 2 indexed citations
19.
Dubuquoy, Laurent, Emmelie Å. Jansson, Samir S. Deeb, et al.. (2003). Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology. 124(5). 1265–1276. 339 indexed citations
20.
Laharie, David, Stéphane Debeugny, Marc Peeters, et al.. (2001). Inflammatory bowel disease in spouses and their offspring. Gastroenterology. 120(4). 816–819. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jack Satsangi Breakdown of academic impact, for papers by Corinne Gower‐Rousseau Breakdown of academic impact, for papers by Lloyd Mayer Breakdown of academic impact, for papers by Curt Tysk Breakdown of academic impact, for papers by Hans Herfarth Breakdown of academic impact, for papers by Antoine Cortot Breakdown of academic impact, for papers by P. Rutgeerts Breakdown of academic impact, for papers by Jacques Bélaïche Breakdown of academic impact, for papers by Francesco Pallone Breakdown of academic impact, for papers by Daniël W. Hommes
Rankless by CCL
2026